Dihydroartemisinin decreases pre-existing neutralizing antibodies against adeno-associated virus in challenged mice.
Saved in:
| Title: | Dihydroartemisinin decreases pre-existing neutralizing antibodies against adeno-associated virus in challenged mice. |
|---|---|
| Authors: | Fang J; Oncology Department of Traditional Chinese Medicine, Changhai Hospital, Naval Medical University, Shanghai, China., Cui E; Oncology Department of Traditional Chinese Medicine, Changhai Hospital, Naval Medical University, Shanghai, China., Xie J; State Key Laboratory of Genetics and Development of Complex Phenotypes and Engineering Research Center of Gene Technology (Ministry of Education), School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China., Gao X; State Key Laboratory of Genetics and Development of Complex Phenotypes and Engineering Research Center of Gene Technology (Ministry of Education), School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China., He Y; State Key Laboratory of Genetics and Development of Complex Phenotypes and Engineering Research Center of Gene Technology (Ministry of Education), School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China., Yang M; State Key Laboratory of Genetics and Development of Complex Phenotypes and Engineering Research Center of Gene Technology (Ministry of Education), School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China., Shaheen S; State Key Laboratory of Genetics and Development of Complex Phenotypes and Engineering Research Center of Gene Technology (Ministry of Education), School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China., Zhou Z; Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China., Zhou S; Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China., Cheng B; Oncology Department of Traditional Chinese Medicine, Changhai Hospital, Naval Medical University, Shanghai, China.; Faculty of Traditional Chinese Medicine, Naval Medical University, Shanghai, China., Ling C; Oncology Department of Traditional Chinese Medicine, Changhai Hospital, Naval Medical University, Shanghai, China.; Faculty of Traditional Chinese Medicine, Naval Medical University, Shanghai, China., Ling C; State Key Laboratory of Genetics and Development of Complex Phenotypes and Engineering Research Center of Gene Technology (Ministry of Education), School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Key Laboratory of Gene Editing and Cell Therapy for Rare Diseases, Fudan University, Shanghai, China.; Institutes of Integrative Medicine, Fudan University, Shanghai, China. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2025 Aug 01; Vol. 16, pp. 1587135. Date of Electronic Publication: 2025 Aug 01 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40822466 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Dihydroartemisinin decreases pre-existing neutralizing antibodies against adeno-associated virus in challenged mice. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Fang+J%22">Fang J</searchLink>; Oncology Department of Traditional Chinese Medicine, Changhai Hospital, Naval Medical University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Cui+E%22">Cui E</searchLink>; Oncology Department of Traditional Chinese Medicine, Changhai Hospital, Naval Medical University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Xie+J%22">Xie J</searchLink>; State Key Laboratory of Genetics and Development of Complex Phenotypes and Engineering Research Center of Gene Technology (Ministry of Education), School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Gao+X%22">Gao X</searchLink>; State Key Laboratory of Genetics and Development of Complex Phenotypes and Engineering Research Center of Gene Technology (Ministry of Education), School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22He+Y%22">He Y</searchLink>; State Key Laboratory of Genetics and Development of Complex Phenotypes and Engineering Research Center of Gene Technology (Ministry of Education), School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Yang+M%22">Yang M</searchLink>; State Key Laboratory of Genetics and Development of Complex Phenotypes and Engineering Research Center of Gene Technology (Ministry of Education), School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Shaheen+S%22">Shaheen S</searchLink>; State Key Laboratory of Genetics and Development of Complex Phenotypes and Engineering Research Center of Gene Technology (Ministry of Education), School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Zhou+Z%22">Zhou Z</searchLink>; Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Zhou+S%22">Zhou S</searchLink>; Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Cheng+B%22">Cheng B</searchLink>; Oncology Department of Traditional Chinese Medicine, Changhai Hospital, Naval Medical University, Shanghai, China.; Faculty of Traditional Chinese Medicine, Naval Medical University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Ling+C%22">Ling C</searchLink>; Oncology Department of Traditional Chinese Medicine, Changhai Hospital, Naval Medical University, Shanghai, China.; Faculty of Traditional Chinese Medicine, Naval Medical University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Ling+C%22">Ling C</searchLink>; State Key Laboratory of Genetics and Development of Complex Phenotypes and Engineering Research Center of Gene Technology (Ministry of Education), School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Key Laboratory of Gene Editing and Cell Therapy for Rare Diseases, Fudan University, Shanghai, China.; Institutes of Integrative Medicine, Fudan University, Shanghai, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2025 Aug 01; Vol. 16, pp. 1587135. <i>Date of Electronic Publication: </i>2025 Aug 01 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40822466 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fphar.2025.1587135 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1587135 Titles: – TitleFull: Dihydroartemisinin decreases pre-existing neutralizing antibodies against adeno-associated virus in challenged mice. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fang J – PersonEntity: Name: NameFull: Cui E – PersonEntity: Name: NameFull: Xie J – PersonEntity: Name: NameFull: Gao X – PersonEntity: Name: NameFull: He Y – PersonEntity: Name: NameFull: Yang M – PersonEntity: Name: NameFull: Shaheen S – PersonEntity: Name: NameFull: Zhou Z – PersonEntity: Name: NameFull: Zhou S – PersonEntity: Name: NameFull: Cheng B – PersonEntity: Name: NameFull: Ling C – PersonEntity: Name: NameFull: Ling C IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2025 Aug 01 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 1663-9812 Numbering: – Type: volume Value: 16 Titles: – TitleFull: Frontiers in pharmacology Type: main |
| ResultId | 1 |